B

Balaxi Pharma

(NSE: BALAXI)

BALAXI

580.1

0.00 (0.00%)

Balaxi Pharma Price Chart

Note: The data used to display charts is delayed by 15 mins as per guidelines.

Balaxi Pharma Price Chart

Note: The data used to display charts is delayed by 15 mins as per guidelines.

Balaxi Pharma Price Summary

Today’s High

600

Today’s Low

565

52 Week's High

600

52 Week's Low

565

Balaxi Pharma Fundamentals

Market Cap

582.3 Cr

CASA

0.0

No. Of Shares

1.0 Cr

P/E

34.7

P/B

12.1

Face Value

10.0

Dividend Yeild

0.0

Book Value

43.2

Net Interest Income

NA

Cost to Income

NA

Promoter Holdings

72.9

EPS

15.1

CAR

NA

ROE

42.4

ROCE

55.4

Profit Growth

NA

Balaxi Pharma Peer Comparison

COMPANY

PRICE

MCAP (cr)

P/B

P/E

EPS

ROE

ROCE

NII

Mirae Asset NYSE FANG+ ETF

39.5

NA

NA

NA

NA

NA

NA

NA

Nippon India ETF Infra BEES

523.65

NA

NA

NA

NA

NA

NA

NA

Nifty Bank

0

NA

NA

NA

NA

NA

NA

NA

BHARAT 22 ETF - ICICI Prudential AMC

52.96

NA

NA

NA

NA

NA

NA

NA

Tata Asset Management Ltd. - (NPBET)

206.42

NA

NA

NA

NA

NA

NA

NA

Nippon India ETF Gold BEES

42.82

NA

NA

NA

NA

NA

NA

NA

FAQ’s on Balaxi Pharma

About Balaxi Pharma

Balaxi Pharmaceuticals Limited is a branded IPR-based pharmaceutical Company focusing on frontier markets, with a vast and growing portfolio of drugs across multiple therapeutic segments. Its markets extend across the continents of Americas, Africa and the Caribbean islands. It is a dynamic and responsible company, with a rich and growing portfolio of branded and generic medicines and consumer products.

Business area of the company

The company is engaged in the business of international wholesale trading of Pharmaceuticals, Builders Hardware and FMCG products

History and Milestones

2003-07
  • Commenced Pharmaceutcal business by supplying white labeled products to customers in Africa.
  • Sourcing was from WHO GMP certified plants based in India.
2008-10
  • Created frontend presence for its Pharmaceutical Business by setting up 1st wholesale depot in Angola in 2008.
2011-13
  • Started sourcing pharmaceutical from WHO GMP certified manufacturers in China by setting up an office in China in 2011.
  • Opened first wholesale depot for its ancillary business in Angola.
2014-16
  • In 2014, the group expanded its pharmaceutical business in Angola by setting up its 12th wholesale depot and a central distribution warehouse.
  • Made in-roads in Dominican Republic pharmaceutical market, submitted technical dossiers for securing product registrations and opened a central distribution warehouse.
2017-19
  • Set-up central distribution warehouse in Guatemala marking the entry of Balaxi into its third geography.
  • Leveraged the vast on-ground infrastructure in Angola by entering branded consumer goods products business in 2019.
2020
  • Submitted several technical dossiers of Pharmaceutical products in EL Salvador and Honduras for product registrations.

Trade Balaxi Pharma today

Create a free portfolio in Trinkerr and earn and grow along with peers